徐淑静, 丁当, 张续杰, 刘新泳*, 展鹏*. 抗病毒药物研究中的新靶标与新策略J. 药学学报, 2022,57(4): 903-916. doi: 10.16438/j.0513-4870.2021-1131
引用本文: 徐淑静, 丁当, 张续杰, 刘新泳*, 展鹏*. 抗病毒药物研究中的新靶标与新策略J. 药学学报, 2022,57(4): 903-916. doi: 10.16438/j.0513-4870.2021-1131
XU Shu-jing, DING Dang, ZHANG Xu-jie, LIU Xin-yong*, ZHAN Peng*. Novel targets and strategies in antiviral drug discoveryJ. Acta Pharmaceutica Sinica, 2022,57(4): 903-916. doi: 10.16438/j.0513-4870.2021-1131
Citation: XU Shu-jing, DING Dang, ZHANG Xu-jie, LIU Xin-yong*, ZHAN Peng*. Novel targets and strategies in antiviral drug discoveryJ. Acta Pharmaceutica Sinica, 2022,57(4): 903-916. doi: 10.16438/j.0513-4870.2021-1131

抗病毒药物研究中的新靶标与新策略

Novel targets and strategies in antiviral drug discovery

  • 摘要: 病毒感染对人类的健康和生命构成了持续性的威胁。耐药株的快速出现及新发病毒疫情的爆发亟需研究人员运用新策略快速开发更多新靶标的抗病毒药物,以满足临床防治的需求。本文精选典型研究案例,从药物化学的角度综述了近几年出现的抗病毒药物新靶标与新策略。

     

    Abstract: Viral infections pose a persistent threat to human health and life. The rapid emergence of drug-resistant strains and the outbreak of new viruses require researchers to develop innovative strategies to accelerate the development of more antiviral drugs towards novel targets to meet the clinical needs. This paper selects typical research cases and reviews the novel targets and strategies of antiviral drugs in recent years from the perspective of medicinal chemistry.

     

/

返回文章
返回